The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Onychomycosis Treatment Market Research Report 2024

Global Onychomycosis Treatment Market Research Report 2024

Publishing Date : May, 2024

License Type :
 

Report Code : 1718691

No of Pages : 95

Ask Your Query

Synopsis

Onychomycosis, also known as tinea unguium, is a fungal infection of the nail. Symptoms may include white or yellow nail discoloration, thickening of the nail, and separation of the nail from the nail bed. Toenails or fingernails may be affected, but it is more common for toenails. Complications may include cellulitis of the lower leg. A number of different types of fungus can cause onychomycosis, including dermatophytes and Fusarium. Risk factors include athlete's foot, other nail diseases, exposure to someone with the condition, peripheral vascular disease, and poor immune function. The diagnosis is generally suspected based on the appearance and confirmed by laboratory testing.

The global Onychomycosis Treatment market was valued at US$ 3290 million in 2023 and is anticipated to reach US$ 4179.7 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Onychomycosis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Onychomycosis Treatment.

Report Scope

The Onychomycosis Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Onychomycosis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Onychomycosis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company (Partial List)

  • Johnson & Johnson
  • GSK
  • Novartis
  • Pfizer
  • Bausch Health
  • Kaken Pharmaceutical
  • Galderma
  • Bayer
  • Lumenis
  • Moberg Pharma
  • Cipla
  • Biofrontera
  • Leo Pharma
  • Dr. Reddy's Laboratories
  • Medimetriks Pharmaceuticals
  • Xiuzheng Pharmaceutical
  • Letai
  • Qilu Pharmaceutical

Segment by Type

  • Oral Medicine
  • External Medicine

Segment by Application

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Onychomycosis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Onychomycosis Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oral Medicine
1.2.3 External Medicine
1.3 Market by Application
1.3.1 Global Onychomycosis Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Onychomycosis Treatment Market Perspective (2019-2030)
2.2 Onychomycosis Treatment Growth Trends by Region
2.2.1 Global Onychomycosis Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Onychomycosis Treatment Historic Market Size by Region (2019-2024)
2.2.3 Onychomycosis Treatment Forecasted Market Size by Region (2025-2030)
2.3 Onychomycosis Treatment Market Dynamics
2.3.1 Onychomycosis Treatment Industry Trends
2.3.2 Onychomycosis Treatment Market Drivers
2.3.3 Onychomycosis Treatment Market Challenges
2.3.4 Onychomycosis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Onychomycosis Treatment Players by Revenue
3.1.1 Global Top Onychomycosis Treatment Players by Revenue (2019-2024)
3.1.2 Global Onychomycosis Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Onychomycosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Onychomycosis Treatment Revenue
3.4 Global Onychomycosis Treatment Market Concentration Ratio
3.4.1 Global Onychomycosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Onychomycosis Treatment Revenue in 2023
3.5 Onychomycosis Treatment Key Players Head office and Area Served
3.6 Key Players Onychomycosis Treatment Product Solution and Service
3.7 Date of Enter into Onychomycosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Onychomycosis Treatment Breakdown Data by Type
4.1 Global Onychomycosis Treatment Historic Market Size by Type (2019-2024)
4.2 Global Onychomycosis Treatment Forecasted Market Size by Type (2025-2030)
5 Onychomycosis Treatment Breakdown Data by Application
5.1 Global Onychomycosis Treatment Historic Market Size by Application (2019-2024)
5.2 Global Onychomycosis Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Onychomycosis Treatment Market Size (2019-2030)
6.2 North America Onychomycosis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Onychomycosis Treatment Market Size by Country (2019-2024)
6.4 North America Onychomycosis Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Onychomycosis Treatment Market Size (2019-2030)
7.2 Europe Onychomycosis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Onychomycosis Treatment Market Size by Country (2019-2024)
7.4 Europe Onychomycosis Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Onychomycosis Treatment Market Size (2019-2030)
8.2 Asia-Pacific Onychomycosis Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Onychomycosis Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Onychomycosis Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Onychomycosis Treatment Market Size (2019-2030)
9.2 Latin America Onychomycosis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Onychomycosis Treatment Market Size by Country (2019-2024)
9.4 Latin America Onychomycosis Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Onychomycosis Treatment Market Size (2019-2030)
10.2 Middle East & Africa Onychomycosis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Onychomycosis Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Onychomycosis Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Detail
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Onychomycosis Treatment Introduction
11.1.4 Johnson & Johnson Revenue in Onychomycosis Treatment Business (2019-2024)
11.1.5 Johnson & Johnson Recent Development
11.2 GSK
11.2.1 GSK Company Detail
11.2.2 GSK Business Overview
11.2.3 GSK Onychomycosis Treatment Introduction
11.2.4 GSK Revenue in Onychomycosis Treatment Business (2019-2024)
11.2.5 GSK Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Onychomycosis Treatment Introduction
11.3.4 Novartis Revenue in Onychomycosis Treatment Business (2019-2024)
11.3.5 Novartis Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Onychomycosis Treatment Introduction
11.4.4 Pfizer Revenue in Onychomycosis Treatment Business (2019-2024)
11.4.5 Pfizer Recent Development
11.5 Bausch Health
11.5.1 Bausch Health Company Detail
11.5.2 Bausch Health Business Overview
11.5.3 Bausch Health Onychomycosis Treatment Introduction
11.5.4 Bausch Health Revenue in Onychomycosis Treatment Business (2019-2024)
11.5.5 Bausch Health Recent Development
11.6 Kaken Pharmaceutical
11.6.1 Kaken Pharmaceutical Company Detail
11.6.2 Kaken Pharmaceutical Business Overview
11.6.3 Kaken Pharmaceutical Onychomycosis Treatment Introduction
11.6.4 Kaken Pharmaceutical Revenue in Onychomycosis Treatment Business (2019-2024)
11.6.5 Kaken Pharmaceutical Recent Development
11.7 Galderma
11.7.1 Galderma Company Detail
11.7.2 Galderma Business Overview
11.7.3 Galderma Onychomycosis Treatment Introduction
11.7.4 Galderma Revenue in Onychomycosis Treatment Business (2019-2024)
11.7.5 Galderma Recent Development
11.8 Bayer
11.8.1 Bayer Company Detail
11.8.2 Bayer Business Overview
11.8.3 Bayer Onychomycosis Treatment Introduction
11.8.4 Bayer Revenue in Onychomycosis Treatment Business (2019-2024)
11.8.5 Bayer Recent Development
11.9 Lumenis
11.9.1 Lumenis Company Detail
11.9.2 Lumenis Business Overview
11.9.3 Lumenis Onychomycosis Treatment Introduction
11.9.4 Lumenis Revenue in Onychomycosis Treatment Business (2019-2024)
11.9.5 Lumenis Recent Development
11.10 Moberg Pharma
11.10.1 Moberg Pharma Company Detail
11.10.2 Moberg Pharma Business Overview
11.10.3 Moberg Pharma Onychomycosis Treatment Introduction
11.10.4 Moberg Pharma Revenue in Onychomycosis Treatment Business (2019-2024)
11.10.5 Moberg Pharma Recent Development
11.11 Cipla
11.11.1 Cipla Company Detail
11.11.2 Cipla Business Overview
11.11.3 Cipla Onychomycosis Treatment Introduction
11.11.4 Cipla Revenue in Onychomycosis Treatment Business (2019-2024)
11.11.5 Cipla Recent Development
11.12 Biofrontera
11.12.1 Biofrontera Company Detail
11.12.2 Biofrontera Business Overview
11.12.3 Biofrontera Onychomycosis Treatment Introduction
11.12.4 Biofrontera Revenue in Onychomycosis Treatment Business (2019-2024)
11.12.5 Biofrontera Recent Development
11.13 Leo Pharma
11.13.1 Leo Pharma Company Detail
11.13.2 Leo Pharma Business Overview
11.13.3 Leo Pharma Onychomycosis Treatment Introduction
11.13.4 Leo Pharma Revenue in Onychomycosis Treatment Business (2019-2024)
11.13.5 Leo Pharma Recent Development
11.14 Dr. Reddy's Laboratories
11.14.1 Dr. Reddy's Laboratories Company Detail
11.14.2 Dr. Reddy's Laboratories Business Overview
11.14.3 Dr. Reddy's Laboratories Onychomycosis Treatment Introduction
11.14.4 Dr. Reddy's Laboratories Revenue in Onychomycosis Treatment Business (2019-2024)
11.14.5 Dr. Reddy's Laboratories Recent Development
11.15 Medimetriks Pharmaceuticals
11.15.1 Medimetriks Pharmaceuticals Company Detail
11.15.2 Medimetriks Pharmaceuticals Business Overview
11.15.3 Medimetriks Pharmaceuticals Onychomycosis Treatment Introduction
11.15.4 Medimetriks Pharmaceuticals Revenue in Onychomycosis Treatment Business (2019-2024)
11.15.5 Medimetriks Pharmaceuticals Recent Development
11.16 Xiuzheng Pharmaceutical
11.16.1 Xiuzheng Pharmaceutical Company Detail
11.16.2 Xiuzheng Pharmaceutical Business Overview
11.16.3 Xiuzheng Pharmaceutical Onychomycosis Treatment Introduction
11.16.4 Xiuzheng Pharmaceutical Revenue in Onychomycosis Treatment Business (2019-2024)
11.16.5 Xiuzheng Pharmaceutical Recent Development
11.17 Letai
11.17.1 Letai Company Detail
11.17.2 Letai Business Overview
11.17.3 Letai Onychomycosis Treatment Introduction
11.17.4 Letai Revenue in Onychomycosis Treatment Business (2019-2024)
11.17.5 Letai Recent Development
11.18 Qilu Pharmaceutical
11.18.1 Qilu Pharmaceutical Company Detail
11.18.2 Qilu Pharmaceutical Business Overview
11.18.3 Qilu Pharmaceutical Onychomycosis Treatment Introduction
11.18.4 Qilu Pharmaceutical Revenue in Onychomycosis Treatment Business (2019-2024)
11.18.5 Qilu Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Onychomycosis Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Oral Medicine
Table 3. Key Players of External Medicine
Table 4. Global Onychomycosis Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Onychomycosis Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Onychomycosis Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Onychomycosis Treatment Market Share by Region (2019-2024)
Table 8. Global Onychomycosis Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Onychomycosis Treatment Market Share by Region (2025-2030)
Table 10. Onychomycosis Treatment Market Trends
Table 11. Onychomycosis Treatment Market Drivers
Table 12. Onychomycosis Treatment Market Challenges
Table 13. Onychomycosis Treatment Market Restraints
Table 14. Global Onychomycosis Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Onychomycosis Treatment Market Share by Players (2019-2024)
Table 16. Global Top Onychomycosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Onychomycosis Treatment as of 2023)
Table 17. Ranking of Global Top Onychomycosis Treatment Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Onychomycosis Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Onychomycosis Treatment Product Solution and Service
Table 21. Date of Enter into Onychomycosis Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Onychomycosis Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Onychomycosis Treatment Revenue Market Share by Type (2019-2024)
Table 25. Global Onychomycosis Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Onychomycosis Treatment Revenue Market Share by Type (2025-2030)
Table 27. Global Onychomycosis Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Onychomycosis Treatment Revenue Market Share by Application (2019-2024)
Table 29. Global Onychomycosis Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Onychomycosis Treatment Revenue Market Share by Application (2025-2030)
Table 31. North America Onychomycosis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Onychomycosis Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Onychomycosis Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Onychomycosis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Onychomycosis Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Onychomycosis Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Onychomycosis Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Onychomycosis Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Onychomycosis Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Onychomycosis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Onychomycosis Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Onychomycosis Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Onychomycosis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Onychomycosis Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Onychomycosis Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 46. Johnson & Johnson Company Detail
Table 47. Johnson & Johnson Business Overview
Table 48. Johnson & Johnson Onychomycosis Treatment Product
Table 49. Johnson & Johnson Revenue in Onychomycosis Treatment Business (2019-2024) & (US$ Million)
Table 50. Johnson & Johnson Recent Development
Table 51. GSK Company Detail
Table 52. GSK Business Overview
Table 53. GSK Onychomycosis Treatment Product
Table 54. GSK Revenue in Onychomycosis Treatment Business (2019-2024) & (US$ Million)
Table 55. GSK Recent Development
Table 56. Novartis Company Detail
Table 57. Novartis Business Overview
Table 58. Novartis Onychomycosis Treatment Product
Table 59. Novartis Revenue in Onychomycosis Treatment Business (2019-2024) & (US$ Million)
Table 60. Novartis Recent Development
Table 61. Pfizer Company Detail
Table 62. Pfizer Business Overview
Table 63. Pfizer Onychomycosis Treatment Product
Table 64. Pfizer Revenue in Onychomycosis Treatment Business (2019-2024) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Bausch Health Company Detail
Table 67. Bausch Health Business Overview
Table 68. Bausch Health Onychomycosis Treatment Product
Table 69. Bausch Health Revenue in Onychomycosis Treatment Business (2019-2024) & (US$ Million)
Table 70. Bausch Health Recent Development
Table 71. Kaken Pharmaceutical Company Detail
Table 72. Kaken Pharmaceutical Business Overview
Table 73. Kaken Pharmaceutical Onychomycosis Treatment Product
Table 74. Kaken Pharmaceutical Revenue in Onychomycosis Treatment Business (2019-2024) & (US$ Million)
Table 75. Kaken Pharmaceutical Recent Development
Table 76. Galderma Company Detail
Table 77. Galderma Business Overview
Table 78. Galderma Onychomycosis Treatment Product
Table 79. Galderma Revenue in Onychomycosis Treatment Business (2019-2024) & (US$ Million)
Table 80. Galderma Recent Development
Table 81. Bayer Company Detail
Table 82. Bayer Business Overview
Table 83. Bayer Onychomycosis Treatment Product
Table 84. Bayer Revenue in Onychomycosis Treatment Business (2019-2024) & (US$ Million)
Table 85. Bayer Recent Development
Table 86. Lumenis Company Detail
Table 87. Lumenis Business Overview
Table 88. Lumenis Onychomycosis Treatment Product
Table 89. Lumenis Revenue in Onychomycosis Treatment Business (2019-2024) & (US$ Million)
Table 90. Lumenis Recent Development
Table 91. Moberg Pharma Company Detail
Table 92. Moberg Pharma Business Overview
Table 93. Moberg Pharma Onychomycosis Treatment Product
Table 94. Moberg Pharma Revenue in Onychomycosis Treatment Business (2019-2024) & (US$ Million)
Table 95. Moberg Pharma Recent Development
Table 96. Cipla Company Detail
Table 97. Cipla Business Overview
Table 98. Cipla Onychomycosis Treatment Product
Table 99. Cipla Revenue in Onychomycosis Treatment Business (2019-2024) & (US$ Million)
Table 100. Cipla Recent Development
Table 101. Biofrontera Company Detail
Table 102. Biofrontera Business Overview
Table 103. Biofrontera Onychomycosis Treatment Product
Table 104. Biofrontera Revenue in Onychomycosis Treatment Business (2019-2024) & (US$ Million)
Table 105. Biofrontera Recent Development
Table 106. Leo Pharma Company Detail
Table 107. Leo Pharma Business Overview
Table 108. Leo Pharma Onychomycosis Treatment Product
Table 109. Leo Pharma Revenue in Onychomycosis Treatment Business (2019-2024) & (US$ Million)
Table 110. Leo Pharma Recent Development
Table 111. Dr. Reddy's Laboratories Company Detail
Table 112. Dr. Reddy's Laboratories Business Overview
Table 113. Dr. Reddy's Laboratories Onychomycosis Treatment Product
Table 114. Dr. Reddy's Laboratories Revenue in Onychomycosis Treatment Business (2019-2024) & (US$ Million)
Table 115. Dr. Reddy's Laboratories Recent Development
Table 116. Medimetriks Pharmaceuticals Company Detail
Table 117. Medimetriks Pharmaceuticals Business Overview
Table 118. Medimetriks Pharmaceuticals Onychomycosis Treatment Product
Table 119. Medimetriks Pharmaceuticals Revenue in Onychomycosis Treatment Business (2019-2024) & (US$ Million)
Table 120. Medimetriks Pharmaceuticals Recent Development
Table 121. Xiuzheng Pharmaceutical Company Detail
Table 122. Xiuzheng Pharmaceutical Business Overview
Table 123. Xiuzheng Pharmaceutical Onychomycosis Treatment Product
Table 124. Xiuzheng Pharmaceutical Revenue in Onychomycosis Treatment Business (2019-2024) & (US$ Million)
Table 125. Xiuzheng Pharmaceutical Recent Development
Table 126. Letai Company Detail
Table 127. Letai Business Overview
Table 128. Letai Onychomycosis Treatment Product
Table 129. Letai Revenue in Onychomycosis Treatment Business (2019-2024) & (US$ Million)
Table 130. Letai Recent Development
Table 131. Qilu Pharmaceutical Company Detail
Table 132. Qilu Pharmaceutical Business Overview
Table 133. Qilu Pharmaceutical Onychomycosis Treatment Product
Table 134. Qilu Pharmaceutical Revenue in Onychomycosis Treatment Business (2019-2024) & (US$ Million)
Table 135. Qilu Pharmaceutical Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Onychomycosis Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Onychomycosis Treatment Market Share by Type: 2023 VS 2030
Figure 3. Oral Medicine Features
Figure 4. External Medicine Features
Figure 5. Global Onychomycosis Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Onychomycosis Treatment Market Share by Application: 2023 VS 2030
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Onychomycosis Treatment Report Years Considered
Figure 11. Global Onychomycosis Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Onychomycosis Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Onychomycosis Treatment Market Share by Region: 2023 VS 2030
Figure 14. Global Onychomycosis Treatment Market Share by Players in 2023
Figure 15. Global Top Onychomycosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Onychomycosis Treatment as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Onychomycosis Treatment Revenue in 2023
Figure 17. North America Onychomycosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Onychomycosis Treatment Market Share by Country (2019-2030)
Figure 19. United States Onychomycosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Onychomycosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Onychomycosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Onychomycosis Treatment Market Share by Country (2019-2030)
Figure 23. Germany Onychomycosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Onychomycosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Onychomycosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Onychomycosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Onychomycosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Onychomycosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Onychomycosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Onychomycosis Treatment Market Share by Region (2019-2030)
Figure 31. China Onychomycosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Onychomycosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Onychomycosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Onychomycosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Onychomycosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Onychomycosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Onychomycosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Onychomycosis Treatment Market Share by Country (2019-2030)
Figure 39. Mexico Onychomycosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Onychomycosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Onychomycosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Onychomycosis Treatment Market Share by Country (2019-2030)
Figure 43. Turkey Onychomycosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Onychomycosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Johnson & Johnson Revenue Growth Rate in Onychomycosis Treatment Business (2019-2024)
Figure 46. GSK Revenue Growth Rate in Onychomycosis Treatment Business (2019-2024)
Figure 47. Novartis Revenue Growth Rate in Onychomycosis Treatment Business (2019-2024)
Figure 48. Pfizer Revenue Growth Rate in Onychomycosis Treatment Business (2019-2024)
Figure 49. Bausch Health Revenue Growth Rate in Onychomycosis Treatment Business (2019-2024)
Figure 50. Kaken Pharmaceutical Revenue Growth Rate in Onychomycosis Treatment Business (2019-2024)
Figure 51. Galderma Revenue Growth Rate in Onychomycosis Treatment Business (2019-2024)
Figure 52. Bayer Revenue Growth Rate in Onychomycosis Treatment Business (2019-2024)
Figure 53. Lumenis Revenue Growth Rate in Onychomycosis Treatment Business (2019-2024)
Figure 54. Moberg Pharma Revenue Growth Rate in Onychomycosis Treatment Business (2019-2024)
Figure 55. Cipla Revenue Growth Rate in Onychomycosis Treatment Business (2019-2024)
Figure 56. Biofrontera Revenue Growth Rate in Onychomycosis Treatment Business (2019-2024)
Figure 57. Leo Pharma Revenue Growth Rate in Onychomycosis Treatment Business (2019-2024)
Figure 58. Dr. Reddy's Laboratories Revenue Growth Rate in Onychomycosis Treatment Business (2019-2024)
Figure 59. Medimetriks Pharmaceuticals Revenue Growth Rate in Onychomycosis Treatment Business (2019-2024)
Figure 60. Xiuzheng Pharmaceutical Revenue Growth Rate in Onychomycosis Treatment Business (2019-2024)
Figure 61. Letai Revenue Growth Rate in Onychomycosis Treatment Business (2019-2024)
Figure 62. Qilu Pharmaceutical Revenue Growth Rate in Onychomycosis Treatment Business (2019-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock